2023 - Research.com Biology and Biochemistry in Germany Leader Award
Biochemistry, Bromodomain, Kinase, Computational biology and Protein structure are his primary areas of study. As a part of the same scientific study, he usually deals with the Biochemistry, concentrating on Biophysics and frequently concerns with Enzyme activator. Bromodomain is a subfield of Acetylation that Stefan Knapp explores.
His study looks at the intersection of Acetylation and topics like Histone with Lysine. He has included themes like Phosphorylation and Drug discovery in his Kinase study. His Computational biology research is multidisciplinary, relying on both Genetics and Recombinant DNA.
His scientific interests lie mostly in Crystal structure, Bromodomain, Kinase, Biochemistry and Cell biology. Stefan Knapp combines subjects such as Biophysics and Stereochemistry with his study of Crystal structure. The study incorporates disciplines such as Chromatin and Computational biology in addition to Bromodomain.
His research in Computational biology intersects with topics in Genetics and Drug discovery. His Kinase study combines topics in areas such as Cancer research, Small molecule and Phosphorylation. His studies in Cell biology integrate themes in fields like Molecular biology and Transcription factor.
The scientist’s investigation covers issues in Kinase, Cell biology, Crystal structure, Crystallography and Computational biology. His Kinase study is related to the wider topic of Biochemistry. His work carried out in the field of Cell biology brings together such families of science as Histone, Transcription factor, Gene and Lysine.
His research links Acetylation with Histone. As a member of one scientific family, Stefan Knapp mostly works in the field of Acetylation, focusing on Epigenetics and, on occasion, Chromatin and Cancer research. His Computational biology research is multidisciplinary, incorporating perspectives in Allosteric regulation, Nucleotide, Proto-oncogene tyrosine-protein kinase Src and Drug discovery.
Stefan Knapp mainly investigates Kinase, Cell biology, Bromodomain, Cancer research and Computational biology. His study on Kinase is covered under Biochemistry. His Cell biology study incorporates themes from Receptor, Transcription factor and Thyroid.
His Bromodomain research integrates issues from Domain family and Regulation of gene expression. His Computational biology study integrates concerns from other disciplines, such as Nuclear receptor, Structure–activity relationship and Drug discovery. His BRD4 research focuses on BET inhibitor and how it connects with Programmed cell death.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Selective inhibition of BET bromodomains.
Panagis Filippakopoulos;Jun Qi;Sarah Picaud;Yao Shen.
Histone recognition and large-scale structural analysis of the human bromodomain family.
Panagis Filippakopoulos;Sarah Picaud;Maria Mangos;Tracy Keates.
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos;Stefan Knapp.
Nature Reviews Drug Discovery (2014)
Protein production and purification.
Nature Methods (2008)
The promise and peril of chemical probes.
Cheryl H. Arrowsmith;James E. Audia;Christopher Austin;Jonathan Baell.
Nature Chemical Biology (2015)
Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases
Charlotta Filling;Kurt D. Berndt;Kurt D. Berndt;Jordi Benach;Stefan Knapp.
Journal of Biological Chemistry (2002)
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
K. L. Kavanagh;K. Guo;James Edward Dunford;James Edward Dunford;James Edward Dunford;X. Wu.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Linear Motif Atlas for Phosphorylation-Dependent Signaling
Martin Lee Miller;Martin Lee Miller;Lars Juhl Jensen;Francesca Diella;Claus Jørgensen.
Science Signaling (2008)
Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome
Alastair J. Barr;Emilie Ugochukwu;Wen Hwa Lee;Oliver N.F. King.
Bromodomains as therapeutic targets.
Susanne Muller;Panagis Filippakopoulos;Stefan Knapp.
Expert Reviews in Molecular Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: